{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:57:46Z","timestamp":1790866666920,"version":"4.1.0"},"reference-count":103,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is associated with heterogeneous cognitive and functional trajectories rather than a single diabetes-specific encephalopathy. This structured narrative review proposes a conceptual, hypothesis-generating exposure\u2013injury\u2013structure\u2013function framework linking metabolic, vascular, and frailty-related exposures with molecular and neurovascular injury, structural change, cognitive decline, and loss of independence. Its contribution is the temporal assignment of measurements, lagged testing between adjacent levels, and comparison with clinical-risk and unordered biomarker models. For example, a study-specific threshold of at least 10% improvement in held-out root-mean-square error for 24\u201336-month executive\/processing-speed decline could indicate incremental value. Repeated failure of a specified temporal link challenges that link; failure to improve prediction rejects incremental predictive value, not biological plausibility. Molecular hypotheses focus on AGE\u2013RAGE signalling, NLRP3\u2013IL-1\u03b2 activation, mitochondrial quality control, endothelial dysfunction, and neuroglial injury, although human timing is uncertain. Sodium\u2013glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are considered complementary therapeutic probes. Both offer systemic benefits, but neither has proven efficacy in preventing cognitive decline or direct target engagement in the human brain. Visceral adiposity, skeletal-muscle health, sarcopenia, sex\/gender, kidney function, co-pathology, and reserve are treated as exposures or modifiers. This framework is intended for longitudinal research, not clinical staging or treatment selection.<\/jats:p>","DOI":"10.3390\/ijms27188342","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:23:56Z","timestamp":1790864636000},"page":"8342","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trajectory-Oriented Brain Vulnerability Framework for Cognitive Decline in Type 2 Diabetes"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2644-3061","authenticated-orcid":false,"given":"Jana","family":"Komel","sequence":"first","affiliation":[{"name":"Diabetes Outpatient Clinic, Community Health Centre Koper, 6000 Koper, Slovenia"},{"name":"Faculty of Health Sciences, University of Primorska, 6310 Izola, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Klen","sequence":"additional","affiliation":[{"name":"Department of Abdominal Surgery, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Wang, H., Tang, G., Wang, L., Tian, X., and Li, R. (2025). Risk Factors for Mild Cognitive Impairment in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1617248"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00592-020-01648-9","article-title":"The Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis","volume":"58","author":"You","year":"2021","journal-title":"Acta Diabetol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","article-title":"Understanding Multifactorial Brain Changes in Type 2 Diabetes: A Biomarker Perspective","volume":"19","author":"Biessels","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ehtewish, H., Arredouani, A., and El-Agnaf, O. (2022). Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116144"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","article-title":"Cerebral Microvascular Complications of Type 2 Diabetes: Stroke, Cognitive Dysfunction, and Depression","volume":"8","author":"Sedaghat","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.expneurol.2019.04.012","article-title":"Insulin Resistance and Hippocampal Dysfunction: Disentangling Peripheral and Brain Causes from Consequences","volume":"318","author":"Grillo","year":"2019","journal-title":"Exp. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106358","DOI":"10.1016\/j.phrs.2022.106358","article-title":"Inside the Diabetic Brain: Insulin Resistance and Molecular Mechanism Associated with Cognitive Impairment and Its Possible Therapeutic Strategies","volume":"182","author":"Dutta","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"W\u0105troba, M., Grabowska, A.D., and Szukiewicz, D. (2023). Effects of Diabetes Mellitus-Related Dysglycemia on the Functions of Blood\u2013Brain Barrier and the Risk of Dementia. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.2187.v1"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kan, W., Qu, M., Wang, Y., Zhang, X., and Xu, L. (2025). A Review of Type 2 Diabetes Mellitus and Cognitive Impairment. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1624472"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Liao, X., Zhang, Y., Xu, J., Yin, J., Li, S., Dong, K., Shi, X., Xu, W., Ma, D., and Chen, X. (2025). Narrative Review on Cognitive Impairment in Type 2 Diabetes: Global Trends and Diagnostic Approaches. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020473"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40035-024-00431-y","article-title":"SGLT2 Inhibitors: A Novel Therapy for Cognitive Impairment via Multifaceted Effects on the Nervous System","volume":"13","author":"Mei","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_12","unstructured":"Alford, S., Johannsen, P., Bentsen, M., Rausch, D.B., Carstensen, L., Jeppesen, R., Martino, G., Jim\u00e9nez-Mausbach, M., and Knudsen, L. (2026, January 18\u201322). Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer\u2019s Disease After 12 Weeks of Subcutaneous Treatment. Presented at the American Academy of Neurology Annual Meeting, Chicago, IL, USA. Available online: https:\/\/sciencehub.novonordisk.com\/congresses\/aan2026\/johannsen0.html."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A Scale for the Quality Assessment of Narrative Review Articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/jama.2021.4001","article-title":"Association Between Age at Diabetes Onset and Subsequent Risk of Dementia","volume":"325","author":"Fayosse","year":"2021","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/s41598-020-64349-x","article-title":"Hyperglycemia and Advanced Glycation End Products Disrupt BBB and Promote Occludin and Claudin-5 Protein Secretion on Extracellular Microvesicles","volume":"10","author":"Rom","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"115374","DOI":"10.1016\/j.bcp.2022.115374","article-title":"Activated AMPK Mitigates Diabetes-Related Cognitive Dysfunction by Inhibiting Hippocampal Ferroptosis","volume":"207","author":"Xie","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1111\/bph.15850","article-title":"Amelioration of Endothelial Dysfunction by Sodium Glucose Co-Transporter 2 Inhibitors: Pieces of the Puzzle Explaining Their Cardiovascular Protection","volume":"179","author":"Li","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chi, H., Song, M., Zhang, J., Zhou, J., and Liu, D. (2023). Relationship between Acute Glucose Variability and Cognitive Decline in Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0289782"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e16698","DOI":"10.7717\/peerj.16698","article-title":"Correlation between Long-Term Glycemic Variability and Cognitive Function in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus: A Retrospective Study","volume":"11","author":"Ding","year":"2023","journal-title":"PeerJ"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cui, X., Abduljalil, A., Manor, B.D., Peng, C.-K., and Novak, V. (2014). Multi-Scale Glycemic Variability: A Link to Gray Matter Atrophy and Cognitive Decline in Type 2 Diabetes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086284"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3233\/JAD-191217","article-title":"Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment","volume":"74","author":"Xia","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wang, D.-Q., Wang, L., Wei, M.-M., Xia, X.-S., Tian, X.-L., Cui, X.-H., and Li, X. (2020). Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.595962"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40520-025-03316-w","article-title":"Blood and Imaging Biomarkers of Blood-Brain Barrier Disruption in Diabetic Individuals with Cognitive Impairment","volume":"38","author":"Qiao","year":"2026","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105848","DOI":"10.1016\/j.neubiorev.2024.105848","article-title":"Microglial Activation and Polarization in Type 2 Diabetes-Related Cognitive Impairment: A Focused Review of Pathogenesis","volume":"165","author":"Tian","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e3841","DOI":"10.1002\/dmrr.3841","article-title":"Progress in the Pathogenesis of Diabetic Encephalopathy: The Key Role of Neuroinflammation","volume":"40","author":"Luo","year":"2024","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbi.2024.03.051","article-title":"Microglial SCAP Deficiency Protects against Diabetes-Associated Cognitive Impairment through Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation","volume":"119","author":"Zhu","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lin, L., Wu, Y., Chen, Z., Huang, L., Wang, L., and Liu, L. (2021). Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated with Pericyte and Blood\u2013Brain Barrier Dysfunction. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.775244"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13195-025-01692-z","article-title":"The Impact of Kidney Function on Alzheimer\u2019s Disease Blood Biomarkers: Implications for Predicting Amyloid-\u03b2 Positivity","volume":"17","author":"Arslan","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wang, D., Liu, J., Zhong, L., Li, S., Zhou, L., Zhang, Q., Li, M., and Xiao, X. (2022). The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Biomarkers of Inflammation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1045235"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ab.2018.03.003","article-title":"Analyzing Mitochondrial Function in Human Peripheral Blood Mononuclear Cells","volume":"549","author":"Hsiao","year":"2018","journal-title":"Anal. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1038\/s41467-026-71141-4","article-title":"Sustained Visceral Fat Loss Is Associated with Attenuated Brain Atrophy and Improved Cognition in Late Midlife","volume":"17","author":"Pachter","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"fcad347","DOI":"10.1093\/braincomms\/fcad347","article-title":"Sarcopenia and Diabetes-Induced Dementia Risk","volume":"6","author":"Sun","year":"2024","journal-title":"Brain Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e66031","DOI":"10.2196\/66031","article-title":"Sarcopenia and Risk of Cognitive Impairment: Cohort and Mendelian Randomization Analyses","volume":"8","author":"Sha","year":"2025","journal-title":"JMIR Aging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"112109","DOI":"10.1016\/j.mce.2023.112109","article-title":"Activation of Mitophagy Improves Cognitive Dysfunction in Diabetic Mice with Recurrent Non-Severe Hypoglycemia","volume":"580","author":"Wu","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/clinem\/dgac580","article-title":"Diabetes Mellitus Is Associated with Higher Serum Neurofilament Light Chain Levels in the General US Population","volume":"108","author":"Ciardullo","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e45602","DOI":"10.1097\/MD.0000000000045602","article-title":"Association between Serum NfL and Cognitive Functioning in Older Adults with Diagnosed Diabetes: A Cross-Sectional Study from NHANES","volume":"104","author":"Li","year":"2025","journal-title":"Medicine"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Thota, R.N., Chatterjee, P., Pedrini, S., Hone, E., Ferguson, J.J.A., Garg, M.L., and Martins, R.N. (2022). Association of Plasma Neurofilament Light Chain with Glycaemic Control and Insulin Resistance in Middle-Aged Adults. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.915449"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ana.25874","article-title":"Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study","volume":"88","author":"Rajan","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Axelsson, T., Zetterberg, H., Blennow, K., Arslan, B., Ashton, N.J., Axelsson, M., Svensson, M.K., Saeed, A., and Guron, G. (2025). Plasma Concentrations of Neurofilament Light, p-Tau231 and Glial Fibrillary Acidic Protein Are Elevated in Patients with Chronic Kidney Disease and Correlate with Measured Glomerular Filtration Rate. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-04130-2"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2458149","DOI":"10.1001\/jamanetworkopen.2024.58149","article-title":"Alzheimer Disease Blood Biomarkers and Cognition Among Individuals with Diabetes and Overweight or Obesity","volume":"8","author":"Mielke","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e70381","DOI":"10.1002\/alz.70381","article-title":"Plasma NfL and GFAP for Predicting VCI and Related Brain Changes in Community and Clinical Cohorts","volume":"21","author":"Raghavan","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.arcmed.2022.06.001","article-title":"Serum Levels of Glial Fibrillary Acidic Protein Association with Cognitive Impairment and Type 2 Diabetes","volume":"53","year":"2022","journal-title":"Arch. Med. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1531","DOI":"10.1212\/WNL.0000000000207706","article-title":"Demographic and Clinical Characteristics Associated with Serum GFAP Levels in an Ethnically Diverse Cohort","volume":"101","author":"Gonzales","year":"2023","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105591","DOI":"10.1016\/j.neuint.2023.105591","article-title":"Function and Therapeutic Value of Astrocytes in Diabetic Cognitive Impairment","volume":"169","author":"Meng","year":"2023","journal-title":"Neurochem. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma Phospho-Tau217 for Alzheimer\u2019s Disease Diagnosis in Primary and Secondary Care Using a Fully Automated Platform","volume":"31","author":"Palmqvist","year":"2025","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e70796","DOI":"10.1002\/alz.70796","article-title":"Combining Plasma P-tau231 and Glial Fibrillary Acidic Protein Produces Higher Discriminative Accuracy for Amyloid Positivity than Other Blood-based Biomarker Combinations","volume":"21","author":"Bolton","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e70535","DOI":"10.1002\/alz.70535","article-title":"Alzheimer\u2019s Association Clinical Practice Guideline on the Use of Blood-Based Biomarkers in the Diagnostic Workup of Suspected Alzheimer\u2019s Disease within Specialized Care Settings","volume":"21","author":"Palmqvist","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1038\/s41598-026-41082-5","article-title":"A Neuroimaging Functional Connectivity Signature of Emotional Conflict Monitoring Predicting Cognitive Decline in Type 2 Diabetes","volume":"16","author":"Cheng","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1038\/s41598-023-35522-9","article-title":"Microstructural Brain Tissue Changes Contribute to Cognitive and Mood Deficits in Adults with Type 2 Diabetes Mellitus","volume":"13","author":"Roy","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1212\/WNL.0000000000001982","article-title":"Type 2 Diabetes Mellitus and Biomarkers of Neurodegeneration","volume":"85","author":"Moran","year":"2015","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"43701","DOI":"10.1038\/srep43701","article-title":"Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and Metabolome","volume":"7","author":"Johnson","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e70575","DOI":"10.1111\/cns.70575","article-title":"ApoE4 Upregulates GSK-3\u03b2 to Aggravate Alzheimer-Like Pathologies and Cognitive Impairment in Type 2 Diabetic Mice","volume":"31","author":"Wang","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.2337\/dc22-0105","article-title":"A Diabetes Genetic Risk Score Is Associated with All-Cause Dementia and Clinically Diagnosed Vascular Dementia in the Million Veteran Program","volume":"45","author":"Litkowski","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00125-020-05101-y","article-title":"Neurocognitive Impairment in Type 2 Diabetes: Evidence for Shared Genetic Aetiology","volume":"63","author":"Mollon","year":"2020","journal-title":"Diabetologia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1111\/dom.15702","article-title":"Type 2 Diabetes, Glycaemic Traits, Structural Brain Capacity and Cognitive Function: A Mendelian Randomization Analysis","volume":"26","author":"Luo","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11556-018-0190-1","article-title":"Exercise or Physical Activity and Cognitive Function in Adults with Type 2 Diabetes, Insulin Resistance or Impaired Glucose Tolerance: A Systematic Review","volume":"15","author":"Zhao","year":"2018","journal-title":"Eur. Rev. Aging Phys. Act."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet Standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","article-title":"Whitepaper: Defining and Investigating Cognitive Reserve, Brain Reserve, and Brain Maintenance","volume":"16","author":"Stern","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc16-0843","article-title":"APOE Genotypes Associate with Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND","volume":"39","author":"Raffield","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Lee, B.C., Choe, Y.M., Suh, G.-H., Choi, I.-G., Lee, J.H., Kim, H.S., Hwang, J., Yi, D., and Kim, J.W. (2022). A Combination of Midlife Diabetes Mellitus and the Apolipoprotein E \u03954 Allele Increase Risk for Cognitive Decline. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.1065117"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00125-009-1497-2","article-title":"Presence of the APOE \u03954 Allele Modifies the Relationship between Type 2 Diabetes and Cognitive Performance: The Maine\u2013Syracuse Study","volume":"52","author":"Dore","year":"2009","journal-title":"Diabetologia"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ware, E.B., Morataya, C., Fu, M., and Bakulski, K.M. (2021). Type 2 Diabetes and Cognitive Status in the Health and Retirement Study: A Mendelian Randomization Approach. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.634767"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Fachim, H.A., Malipatil, N., Siddals, K., Donn, R., Cort\u00e9s, G.Y., Dalton, C.F., Gibson, J.M., and Heald, A.H. (2022). Methylation Status of Exon IV of the Brain-Derived Neurotrophic Factor (BDNF)-Encoding Gene in Patients with Non-Diabetic Hyperglycaemia (NDH) before and after a Lifestyle Intervention. Epigenomes, 6.","DOI":"10.3390\/epigenomes6010007"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wang, J., Wang, S., Wang, J., Xiao, M., Guo, Y., Tang, Y., Zhang, J., and Gu, J. (2021). Epigenetic Regulation Associated with Sirtuin 1 in Complications of Diabetes Mellitus. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.598012"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"He, W., Chang, F., Wang, T., Sun, B., Chen, R., and Zhao, L. (2024). Serum Brain-Derived Neurotrophic Factor Levels in Type 2 Diabetes Mellitus Patients and Its Association with Cognitive Impairment: A Meta-Analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0297785"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"SPRINT MIND Investigators for the SPRINT Research Group, Williamson, J.D., Pajewski, N.M., Auchus, A.P., Bryan, R.N., Chelune, G., Cheung, A.K., Cleveland, M.L., Coker, L.H., and Crowe, M.G. (2019). Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA, 321, 553\u2013561.","DOI":"10.1001\/jama.2018.21442"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 Year Multidomain Intervention of Diet, Exercise, Cognitive Training, and Vascular Risk Monitoring versus Control to Prevent Cognitive Decline in at-Risk Elderly People (FINGER): A Randomised Controlled Trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.124.069568","article-title":"Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis","volume":"149","author":"Patel","year":"2024","journal-title":"Circulation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT2 Inhibitors in Patients with Heart Failure: A Comprehensive Meta-Analysis of Five Randomised Controlled Trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lee, H., Park, S.-E., and Kim, E.-Y. (2021). Glycemic Variability Impacted by SGLT2 Inhibitors and GLP 1 Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184078"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e209805","DOI":"10.1212\/WNL.0000000000209805","article-title":"SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients with Type 2 Diabetes","volume":"103","author":"Kim","year":"2024","journal-title":"Neurology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2337\/dc22-1705","article-title":"Association of Sodium\u2013Glucose Cotransporter 2 Inhibitors with Time to Dementia: A Population-Based Cohort Study","volume":"46","author":"Wu","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/jgs.18306","article-title":"Newer Glucose-Lowering Drugs and Risk of Dementia: A Systematic Review and Meta-Analysis of Observational Studies","volume":"71","author":"Tang","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e079475","DOI":"10.1136\/bmj-2024-079475","article-title":"Risk of Dementia after Initiation of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Adults Aged 40\u201369 Years with Type 2 Diabetes: Population Based Cohort Study","volume":"386","author":"Shin","year":"2024","journal-title":"BMJ"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaneurol.2025.0353","article-title":"GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias","volume":"82","author":"Tang","year":"2025","journal-title":"JAMA Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamainternmed.2025.1189","article-title":"Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial","volume":"185","author":"Luchsinger","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Youn, Y.J., Kim, S., Jeong, H.-J., Ah, Y.-M., and Yu, Y.M. (2024). Sodium-Glucose Cotransporter-2 Inhibitors and Their Potential Role in Dementia Onset and Cognitive Function in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Front. Neuroendocrinol., 73.","DOI":"10.1016\/j.yfrne.2024.101131"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"The EMPA-KIDNEY Collaborative Group (2023). Empagliflozin in Patients with Chronic Kidney Disease. N. Engl. J. Med., 388, 117\u2013127.","DOI":"10.1056\/NEJMoa2204233"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Song, K., Choi, J., Jeong, D., Shin, D., Ah, Y.-M., Lee, K.Y., and Choi, K.H. (2025). Comparative Effects of SGLT2 Inhibitors and Incretin-Based Therapies on Dementia Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1695075"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e105271","DOI":"10.1136\/bmjopen-2025-105271","article-title":"Comparative Risk of the Neurodegenerative Outcomes between Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors and Thiazolidinediones in Type 2 Diabetes: A Multicentre Cohort Study Using the Korean Healthcare Database (2014\u20132025)","volume":"16","author":"Park","year":"2026","journal-title":"BMJ Open"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e2590","DOI":"10.1210\/clinem\/dgac043","article-title":"Effects of Dapagliflozin and Combination Therapy with Exenatide on Food-Cue Induced Brain Activation in Patients with Type 2 Diabetes","volume":"107","author":"Veltman","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Watt, C., Sanchez-Rangel, E., and Hwang, J.J. (2020). Glycemic Variability and CNS Inflammation: Reviewing the Connection. Nutrients, 12.","DOI":"10.3390\/nu12123906"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to Fatty Substrate Utilization in Response to Sodium\u2013Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients with Type 2 Diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/13872877251329474","article-title":"Neuroprotective Effects of SGLT2 Inhibitors Empagliflozin and Dapagliflozin on A\u03b21\u201342-Induced Neurotoxicity and Neuroinflammation in Cellular Models of Alzheimer\u2019s Disease","volume":"105","author":"Alami","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41366-020-0535-5","article-title":"Liraglutide Improves Memory in Obese Patients with Prediabetes or Early Type 2 Diabetes: A Randomized, Controlled Study","volume":"44","author":"Vadini","year":"2020","journal-title":"Int. J. Obes."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e020734","DOI":"10.1161\/JAHA.120.020734","article-title":"Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/dc21-2064","article-title":"Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients with Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study","volume":"45","author":"Cheng","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of Dulaglutide on Cognitive Impairment in Type 2 Diabetes: An Exploratory Analysis of the REWIND Trial","volume":"19","author":"Gerstein","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_90","first-page":"e12268","article-title":"Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia: Data from Pooled Double-Blind Randomized Controlled Trials and Nationwide Disease and Prescription Registers","volume":"8","author":"Friedrich","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e71391","DOI":"10.1002\/alz.71391","article-title":"Dulaglutide and Neurodegeneration Biomarkers: REWIND Post Hoc Analysis","volume":"22","author":"Wilson","year":"2026","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Cassataro, G., Scriffignano, S., Geraci, G., Augello, G., Grasso, M.A., D\u2019Ippolito, M.E., Puleo, M.G., Cadelo, M., Renda, M., and Tuttolomondo, A. (2026). Impact of Semaglutide on Cognitive Function in Patients with Type 2 Diabetes and Mild Cognitive Impairment: A 24-Month Observational Study. Intern. Emerg. Med., online ahead of print.","DOI":"10.1007\/s11739-026-04468-x"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1002\/alz.14313","article-title":"Associations of Semaglutide with First-Time Diagnosis of Alzheimer\u2019s Disease in Patients with Type 2 Diabetes: Target Trial Emulation Using Nationwide Real-World Data in the US","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.7326\/ANNALS-24-02648","article-title":"Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia among Older Adults with Type 2 Diabetes: A Target Trial Emulation","volume":"178","author":"Inoue","year":"2025","journal-title":"Ann. Intern. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41591-025-04106-7","article-title":"Liraglutide in Mild to Moderate Alzheimer\u2019s Disease: A Phase 2b Clinical Trial","volume":"32","author":"Edison","year":"2026","journal-title":"Nat. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(26)00459-9","article-title":"Efficacy and Safety of Oral Semaglutide 14 mg (Flexible Dose) in Early-Stage Symptomatic Alzheimer\u2019s Disease (evoke and evoke+): Two Phase 3, Randomised, Placebo-Controlled Trials","volume":"407","author":"Cummings","year":"2026","journal-title":"Lancet"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised Criteria for Diagnosis and Staging of Alzheimer\u2019s Disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular Pathways to Neurodegeneration in Alzheimer\u2019s Disease and Other Disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13098-025-02003-0","article-title":"Temporal Dynamic of Cognitive Decline in Type 2 Diabetes Mellitus Patients: A Multimodal Biomarker Analysis Using Event-Based Modal and Principal Component Analysis","volume":"17","author":"Ni","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1037\/a0038889","article-title":"A Critique of the Cross-Lagged Panel Model","volume":"20","author":"Hamaker","year":"2015","journal-title":"Psychol. Methods"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e823","DOI":"10.1212\/WNL.0000000000006955","article-title":"for the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Type 2 Diabetes Mellitus, Brain Atrophy, and Cognitive Decline","volume":"92","author":"Moran","year":"2019","journal-title":"Neurology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e70053","DOI":"10.1002\/dmrr.70053","article-title":"Associations of Prediabetes, Diabetes and Glucose-Related Markers with Cognition and Neuroimaging in a 2-Year Multidomain Lifestyle Randomised Controlled Trial","volume":"41","author":"Lorenzo","year":"2025","journal-title":"Diabetes Metab. Res. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8342\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:24:43Z","timestamp":1790864683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":103,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188342"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188342","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]}}}